Reports for FRESENIUS KABI CANADA LTD

Company Name

FRESENIUS KABI CANADA LTD

Totals

Shortage reports

310

Actual shortage: 12 (4%)
Anticipated shortage: 1 (0%)
Avoided shortage: 5 (2%)
Resolved: 292 (94%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

48 (15%)

Overdue reports

4 (31%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SODIUM CHLORIDE INJECTION, USP 234MG SOLUTION Resolved 2024-03-06 2024-05-06 221460
LINEZOLID INJECTION 2MG SOLUTION Resolved 2024-03-19 2024-04-22 222722
ADENOSINE INJECTION 3MG SOLUTION Resolved 2024-03-19 2024-05-18 222725
MOXIFLOXACIN INJECTION 400MG SOLUTION Actual shortage 2024-04-04 2024-05-02 224325
OXYTOCIN INJECTION, USP 10UNIT SOLUTION Actual shortage 2024-04-17 2024-05-24 225346
AMPICILLIN FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2024-04-29 2024-05-16 226471
PENICILLIN G SODIUM FOR INJECTION, USP 10000000UNIT POWDER FOR SOLUTION Actual shortage 2024-04-29 2024-06-10 226550
TOBRAMYCIN FOR INJECTION 1.2G POWDER FOR SOLUTION Actual shortage 2024-05-31 2024-06-02 229350
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP 10MG SOLUTION Actual shortage 2024-06-10 2024-06-10 230030
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP 2MG SOLUTION Anticipated shortage 2024-06-10 2024-06-10 230033

Showing 301 to 310 of 310

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0